Ernexa Therapeutics Inc. short interest in 2019
In 2019, Ernexa Therapeutics Inc.'s disclosed short interest ran from 1.21% of shares outstanding on 15 Jan 2019 to 0.03% on 31 Dec 2019, a change of -1.18 percentage points. The year's high was 1.46% on 31 Jan 2019 and its low 0.02% on 15 Aug 2019, averaging 0.61% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.47 days on 15 Apr 2019. Full history: Ernexa Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 1.21% (15 Jan 2019)
- End of year
- 0.03% (31 Dec 2019)
- Change
- -1.18 pp
- High
- 1.46% (31 Jan 2019)
- Low
- 0.02% (15 Aug 2019)
- Average
- 0.61%
- Highest days to cover
- 8.47 (15 Apr 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 1.21% | 1.00 | |
| 31 Jan 2019 | 1.46% | 1.38 | |
| 15 Feb 2019 | 1.37% | 4.59 | |
| 28 Feb 2019 | 1.37% | 5.88 | |
| 15 Mar 2019 | 1.35% | 7.83 | |
| 29 Mar 2019 | 1.16% | 3.59 | results (8-K), 10-K filed |
| 15 Apr 2019 | 1.13% | 8.47 | |
| 30 Apr 2019 | 1.00% | 4.33 | |
| 15 May 2019 | 0.89% | 4.32 | results (8-K), 10-Q filed |
| 31 May 2019 | 0.98% | 6.42 | |
| 14 Jun 2019 | 0.81% | 4.45 | |
| 28 Jun 2019 | 0.63% | 3.64 | |
| 15 Jul 2019 | 0.33% | 1.78 | |
| 15 Aug 2019 | 0.02% | 1.00 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 0.04% | 1.00 | |
| 13 Sep 2019 | 0.03% | 1.00 | |
| 30 Sep 2019 | 0.03% | 1.00 | |
| 15 Oct 2019 | 0.03% | 1.00 | |
| 31 Oct 2019 | 0.05% | 1.00 | results (8-K) |
| 15 Nov 2019 | 0.03% | 1.00 | 10-Q filed |
| 29 Nov 2019 | 0.02% | 1.00 | |
| 13 Dec 2019 | 0.02% | 1.00 | |
| 31 Dec 2019 | 0.03% | 1.00 |
See also: Ernexa Therapeutics Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.